CanFite Biopharma

CANF

TEL AVIV STOCK EXCHANGEHealth Care

Income Statement

Total Revenue$2.9M

Gross Profit$2.9M

Operating Income$-32.72M

EBITDA$-30.41M

EBIT$-30.78M

Pre-tax Income$-26.54M

Net Income$-30.78M

Cash Equivalent$4.64M

Total Debt$64.5K

Book Value$4.16M

Book Value Per Share8.89

Return on Equity (ROE)-144.96%

Return on Assets (ROA)-86.40%

Return on Invested Capital (ROI)-144.96%

Net Profit Margin-1169.14%

Current Ratio4.38

Quick Ratio3.88

Long-Term Debt / Equitynull